Nurix Therapeutics (NRIX) Shares Outstanding (Diluted) (2020 - 2026)
Nurix Therapeutics (NRIX) recorded Shares Outstanding (Diluted) of 111.08 million in fiscal Q2 2026 (quarter ended May 31, 2026), up 32.4% from 83.88 million a year earlier and up 0.9% from the prior quarter.
Powered by 
Analysis
Nurix Therapeutics (NRIX) Shares Outstanding (Diluted) (2020 - 2026) Analysis & Trends
For FY2025 (ended Nov 30, 2025), Nurix Therapeutics reported Shares Outstanding (Diluted) of 86.67 million, up 29.1% from FY2024.
- Annual Shares Outstanding (Diluted) has increased for five straight fiscal years, with a five-year compound annual growth rate of 38.6% (FY2020 to FY2025).
- Across earlier fiscal years, Shares Outstanding (Diluted) came in at 67.12 million in FY2024 (+23.5%), 54.34 million in FY2023 (+11.8%), 48.61 million in FY2022 (+13.3%) and 42.9 million in FY2021 (+153.3%).
- The fiscal Q2 2026 figure is the highest quarterly Shares Outstanding (Diluted) in data going back to fiscal Q2 2020.
- On a year-over-year basis, Shares Outstanding (Diluted) has increased for 21 consecutive quarters, with growth averaging 31.6% over the last eight quarters.
- The year-over-year growth in Shares Outstanding (Diluted) has ranged between 1.6% (fiscal Q1 2024) and 163.9% (fiscal Q1 2022) over the last five years.
- Per Business Quant, the preceding three fiscal quarters came in at 110.07 million (Q1 2026), 86.67 million (Q4 2025) and 84.16 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Dil.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 2.44 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 1.77 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 2.47 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 1.96 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 1.56 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 544.00 Mn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 1.24 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 5.70 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 255.20 Mn |
| 10 | Nurix Therapeutics | 2.46 Bn | 452.73 Mn | - | 111.08 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| May 31, 2026 | 111.08 Mn |
| Feb 28, 2026 | 110.07 Mn |
| Nov 30, 2025 | 86.67 Mn |
| Aug 31, 2025 | 84.16 Mn |
| May 31, 2025 | 83.88 Mn |
| Feb 28, 2025 | 83.56 Mn |
| Nov 30, 2024 | 67.12 Mn |
| Aug 31, 2024 | 72.78 Mn |
| May 31, 2024 | 62.38 Mn |
| Feb 29, 2024 | 54.90 Mn |
| Nov 30, 2023 | 54.34 Mn |
| Aug 31, 2023 | 54.39 Mn |
| May 31, 2023 | 54.26 Mn |
| Feb 28, 2023 | 54.03 Mn |
| Nov 30, 2022 | 48.61 Mn |
| Aug 31, 2022 | 50.87 Mn |
| May 31, 2022 | 44.90 Mn |
| Feb 28, 2022 | 44.69 Mn |
| Nov 30, 2021 | 42.90 Mn |
| Aug 31, 2021 | 44.37 Mn |
API Access
Nurix Therapeutics Shares Outstanding (Diluted) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=shares-outstanding-diluted&ticker=NRIX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "shares-outstanding-diluted", "ticker": "NRIX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=shares-outstanding-diluted&ticker=NRIX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();